Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-12-18, Stock:LLY, The news for the past five days is as follows:
2020-12-11: NEWS1: Eli Lilly (LLY) Dips More Than Broader Markets: What You Should Know.NEWS2: Thiel-Backed Developer of Covid-19 Therapy Surges in Debut.NEWS3: COVID SCIENCE-Drug combination improves COVID-19 pneumonia outcomes; five genes linked to severe disease.NEWS4: Data from ACTT-2 Trial of Baricitinib in Hospitalized COVID-19 Patients Supportive of the EUA Published in New England Journal of Medicine.NEWS5: Five key severe COVID-19 genes found, suggesting drug targets.NEWS6: Pharma Stock Roundup: FDA Panel's Nod to PFE/BNTX Coronavirus Vaccine, Other Updates.
2020-12-14: NEWS1: Eli Lilly raises dividend by 15%.NEWS2: Lilly Announces 15 Percent Dividend Increase.NEWS3: Lilly announces opening of patient enrollment for New IDEAS: Imaging Dementia - Evidence for Amyloid Scanning study.
2020-12-15: NEWS1: Christmas Came Early for Eli Lilly Shareholders.NEWS2: This Gene Therapy Stock Is Ablaze On Eli Lilly's $1.04 Billion Takeover.NEWS3: US STOCKS-Nasdaq ends at record high on stimulus bets, Apple boost.NEWS4: Why Eli Lilly Stock Jumped Today.NEWS5: Eli Lilly Acquiring Prevail Therapeutics in $880 Million Deal.NEWS6: US STOCKS-Stimulus optimism and Apple spark Wall Street rally.NEWS7: US STOCKS-Wall St supported by Apple, stimulus bets as Fed takes center stage.NEWS8: Why Plug Power and Prevail Therapeutics Gave the Stock Market a Boost Tuesday Morning.NEWS9: Why Prevail Therapeutics Stock Is Skyrocketing Today.NEWS10: Eli Lilly to Buy Prevail Therapeutics in $1.04 Billion Deal, Shares Soar.NEWS11: Eli Lilly Lifts Sales Guidance, Enters Gene Therapy Field With Prevail Acquisition.NEWS12: Eli Lilly to Buy Prevail for $1 Billion in Parkinson’s Push.NEWS13: US STOCKS-Wall Street gains on Apple, stimulus hopes as Fed takes center stage.NEWS14: Dow Jones Rebounds, Stocks Climb On Stimulus Compromise; Baidu Looks Into EVs, Apple Boosts iPhone Output.NEWS15: P/E Ratio Insights for Eli Lilly.NEWS16: Eli Lilly and Company -- Moody's announces completion of a periodic review of ratings of Eli Lilly and Company.NEWS17: Return On Capital Employed Overview: Eli Lilly.NEWS18: Lilly Sees Gains from Fighting Covid and Buys into Gene Therapy.NEWS19: Eli Lilly Boosts Profit Guidance, Buys Prevail Therapeutics For $1 Billion.NEWS20: Dow Jones Rebounds, Futures Climb On Stimulus Compromise; Baidu Looks Into EVs, Apple To Boost iPhone Output.NEWS21: US STOCKS-Wall Street set to rise on stimulus hopes; Fed meet in focus.NEWS22: Eli Lilly, Prevail Therapeutics, Boeing - Tuesday's Premarket Movers.NEWS23: Eli Lilly's stock rallies after raising full-year profit outlook.NEWS24: Lilly Announces 2021 Financial Guidance, Updates 2020 Guidance.NEWS25: Prevail Therapeutics stock nearly doubles after Eli Lilly buyout deal.NEWS26: Lilly Announces Agreement to Acquire Prevail Therapeutics.NEWS27: Eli Lilly Raises Dividend by 15%.
2020-12-16: NEWS1: U.S. hospital demand for Lilly, Regeneron COVID-19 antibody drugs  'disappointing'.NEWS2: SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Prevail Therapeutics Inc. Buyout.NEWS3: Top Analyst Reports for Mastercard, Eli Lilly & Citigroup.NEWS4: PREVAIL THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PRVL and Encourages Investors to Contact the Firm.NEWS5: Lilly (LLY) to Acquire Prevail Therapeutics for Gene Therapies.NEWS6: Company News for Dec 16, 2020.NEWS7: Lilly (LLY) Stock Up on Raised 2020 View, Upbeat 2021 Guidance.
2020-12-17: NEWS1: Eli Lilly (LLY) Gains But Lags Market: What You Should Know.NEWS2: The Zacks Analyst Blog Highlights: Mastercard, Eli Lilly, Citigroup, Advanced Micro Devices and Square.NEWS3: Bluebird Bio, Biomarin Tabbed as Top Acquisition Targets.NEWS4: PREVAIL THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prevail Therapeutics Inc. - PRVL.

Answer: Decrease